Robert J. Fontana MDProfessor of Medicine; Medical Director of Liver Transplantation, University of Michigan, Ann Arbor, Michigan
Dr. Fontana is a translational investigator with research interests in drug induced liver injury, acute liver failure, and viral hepatitis. Dr. Fontana is currently a Professor of Medicine and Medical Director of Liver Transplantation. He is a site investigator and co-chair of the Drug Induced Liver Injury Network (DILIN), an NIH consortium of sites investigating the pathogenesis and outcomes of DILI. Dr. Fontana is also the current Chair of the AASLD Hepatotoxicity Special Interest Group and has been a leading member of the US Acute Liver Failure Study Group since 1998.
Dr. Fontana receives research funding from the National Institutes of Health, Gilead Sciences, Bristol-MyersSquibb, Janssen pharmaceuticals, and Vertex.